======= FANCF =======
== Gene Information ==
* **Official Symbol**: FANCF
* **Official Name**: FA complementation group F
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2188|2188]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9NPI8|Q9NPI8]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=FANCF&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FANCF|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/613897|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group F. [provided by RefSeq, Jul 2008].
* **UniProt Summary**: DNA repair protein that may operate in a postreplication repair or a cell cycle checkpoint function. May be implicated in interstrand DNA cross-link repair and in the maintenance of normal chromosome stability (By similarity). {ECO:0000250}.
|FANCF|
|Fanconi anaemia nuclear complex|
|interstrand cross-link repair|
|DNA repair|
|DNA metabolic process|
|molecular function|
|cellular response to DNA damage stimulus|
|cellular response to stress|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp273|Cisplatin 0.35μM R06 exp273]]|-1.99|
|[[:results:exp10|CCCP 0.1μM R00 exp10]]|1.71|
|[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|1.78|
^Gene^Correlation^
|[[:human genes:f:fancg|FANCG]]|0.482|
|[[:human genes:f:fancm|FANCM]]|0.437|
|[[:human genes:h:hgc6.3|HGC6.3]]|0.433|
|[[:human genes:n:nip7|NIP7]]|0.426|
|[[:human genes:f:fancd2|FANCD2]]|0.412|
Global Fraction of Cell Lines Where Essential: 18/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|4/28|
|bone|2/26|
|breast|1/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|1/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|1/16|
|ovary|2/26|
|pancreas|0/24|
|peripheral nervous system|1/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|1/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|1/29|
|uterus|1/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 1031
* **Expression level (log2 read counts)**: 4.76
{{:chemogenomics:nalm6 dist.png?nolink |}}